Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Erosion of implanted urethral bulking agent to surrounding organ or tissue, initial encounter
Summary
Erosion of implanted urethral bulking agent occurs when the material used to treat conditions like stress urinary incontinence wears through or into adjacent organs or tissues. This can lead to tissue damage, discomfort, and complications requiring medical evaluation and intervention.
Causes
The condition may result from factors such as improper surgical technique, infection, inflammation, or the body's reaction to the bulking agent. Over time, physical stress or degradation of the implant may also contribute to erosion.
Risk Factors
- Prior surgeries involving urethral implants
- Infections or chronic inflammation
- Physical activity placing stress on the implant site
- Smoking or conditions affecting healing
- Individual sensitivity to foreign materials
Symptoms
- Pain or discomfort at the implant site
- Abnormal discharge or bleeding
- Urinary problems, such as incontinence or urgency
- Signs of tissue exposure or damage
- Infection-related symptoms (e.g., fever, redness)
Diagnosis
Diagnosis typically involves a physical examination to assess the implant site and surrounding tissues. Imaging studies like ultrasound or MRI may be used to evaluate the extent of erosion. Additional procedures, such as cystoscopy, might be performed for detailed assessment of affected tissues or organs.
Treatment Options
Treatment may include non-surgical management, such as observation or medication, or surgical intervention to remove or repair the eroded material. The approach depends on the severity of symptoms and tissue involvement.
Prognosis and Follow-Up
Prognosis varies based on the extent of erosion and response to treatment. Follow-up care often involves monitoring for recurrence or complications, with regular evaluations to assess healing and function.
Complications
Potential complications include infection, persistent pain, urinary dysfunction, or further tissue damage. In severe cases, additional surgeries may be necessary to address these issues.
Lifestyle & Prevention
Maintaining good hygiene, avoiding activities that strain the implant site, and managing underlying conditions (e.g., infections) may help reduce risk. Smoking cessation and proper wound care after surgery are also important.
When to Seek Professional Help
Seek medical attention if you experience worsening pain, abnormal discharge, bleeding, or urinary problems after a urethral bulking agent procedure. Prompt evaluation can prevent further complications.
Tips for Medical Coders
Document the initial encounter and specify the erosion of the implanted urethral bulking agent to surrounding organ or tissue. Include details about the affected site, symptoms, and any diagnostic or treatment interventions performed. Ensure documentation supports the use of code T83.713A.
T83.713A policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.